<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although a few reports in recent years have suggested that patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) are prone to developing <z:e sem="disease" ids="C0406550" disease_type="Disease or Syndrome" abbrv="">primary anetoderma</z:e> (PA), it is still unclear how often aPL are detected in unselected PA patients </plain></SENT>
<SENT sid="1" pm="."><plain>We studied nine consecutive PA patients for the presence of autoimmune antibodies and disorders in general and the presence of aPL in particular </plain></SENT>
<SENT sid="2" pm="."><plain>Six of the nine patients had clinical evidence of associated <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> (<z:e sem="disease" ids="C0018213" disease_type="Disease or Syndrome" abbrv="">Graves'disease</z:e> and autoimmune haemolysis in one, systemic <z:hpo ids='HP_0100324'>scleroderma</z:hpo> in one, <z:hpo ids='HP_0000872'>Hashimoto's thyroiditis</z:hpo> in one, <z:hpo ids='HP_0002229'>alopecia areata</z:hpo> in one) and/or signs of <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> (recurrent fetal loss in two, recurrent stokes in one, <z:hpo ids='HP_0004850'>recurrent deep vein thrombosis</z:hpo> in one) </plain></SENT>
<SENT sid="3" pm="."><plain>In four ofthese six patients the <z:hpo ids='HP_0003674'>onset</z:hpo> of PA preceded these signs </plain></SENT>
<SENT sid="4" pm="."><plain>Positive aPL was found in <z:hpo ids='HP_0000001'>all</z:hpo>: anticardiolipin (aCL) in six, anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-I (a(beta)2GPI) in six and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) in four </plain></SENT>
<SENT sid="5" pm="."><plain>The most frequent isotype was IgA </plain></SENT>
<SENT sid="6" pm="."><plain>Among other autoantibodies found the most frequently was <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Four ofthe nine patients fulfilled the criteria for <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="8" pm="."><plain>It is concluded that PA is an important cutaneous sign for <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> in general and the presence of aPL in particular </plain></SENT>
<SENT sid="9" pm="."><plain>Hence, the work-up of these patients should include testing for LAC as well as for <z:hpo ids='HP_0000001'>all</z:hpo> different isotypes ofaCL and a(beta)2GPI </plain></SENT>
<SENT sid="10" pm="."><plain>We recommend that PA be added to the list of the cutaneous manifestations of APS </plain></SENT>
</text></document>